Casdin Capital as of Dec. 31, 2024
Portfolio Holdings for Casdin Capital
Casdin Capital holds 38 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 17.9 | $270M | 3.5M | 76.86 | |
| Biolife Solutions Com New (BLFS) | 15.0 | $226M | 8.7M | 25.96 | |
| Revolution Medicines (RVMD) | 10.8 | $162M | 3.7M | 43.74 | |
| Sarepta Therapeutics (SRPT) | 8.7 | $131M | 1.1M | 121.59 | |
| D Fluidigm Corp Del (LAB) | 8.3 | $125M | 71M | 1.75 | |
| Illumina (ILMN) | 6.7 | $100M | 750k | 133.63 | |
| Avidity Biosciences Ord (RNA) | 4.0 | $60M | 2.0M | 29.08 | |
| Codexis (CDXS) | 2.6 | $39M | 8.1M | 4.77 | |
| Relay Therapeutics (RLAY) | 2.5 | $37M | 8.9M | 4.12 | |
| EXACT Sciences Corporation (EXAS) | 2.4 | $37M | 650k | 56.19 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $33M | 140k | 235.31 | |
| Beam Therapeutics (BEAM) | 2.1 | $31M | 1.3M | 24.80 | |
| Neurogene (NGNE) | 2.0 | $30M | 1.3M | 22.86 | |
| Blueprint Medicines (BPMC) | 1.9 | $29M | 326k | 87.22 | |
| Intellia Therapeutics (NTLA) | 1.6 | $23M | 2.0M | 11.66 | |
| Verve Therapeutics (VERV) | 1.5 | $23M | 4.0M | 5.64 | |
| Denali Therapeutics (DNLI) | 1.3 | $20M | 990k | 20.38 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $19M | 700k | 27.12 | |
| Moderna (MRNA) | 1.0 | $15M | 350k | 41.58 | |
| Septerna (SEPN) | 0.8 | $13M | 553k | 22.90 | |
| Veracyte (VCYT) | 0.7 | $11M | 276k | 39.60 | |
| Guardant Health (GH) | 0.7 | $11M | 350k | 30.55 | |
| Tenaya Therapeutics (TNYA) | 0.6 | $9.6M | 6.7M | 1.43 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $8.2M | 250k | 32.86 | |
| 4d Molecular Therapeutics In (FDMT) | 0.4 | $6.4M | 1.2M | 5.57 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $6.3M | 475k | 13.22 | |
| 2seventy Bio Common Stock | 0.4 | $5.9M | 2.0M | 2.94 | |
| Century Therapeutics (IPSC) | 0.3 | $5.2M | 5.2M | 1.01 | |
| Fortrea Hldgs Common Stock (FTRE) | 0.3 | $5.1M | 275k | 18.65 | |
| Contineum Therapeutics Cl A (CTNM) | 0.3 | $4.3M | 297k | 14.65 | |
| Tango Therapeutics (TNGX) | 0.2 | $3.7M | 1.2M | 3.09 | |
| Absci Corp (ABSI) | 0.2 | $2.5M | 973k | 2.62 | |
| Pacific Biosciences of California (PACB) | 0.1 | $1.9M | 1.0M | 1.83 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $1.1M | 165k | 6.76 | |
| Prime Medicine (PRME) | 0.1 | $1.1M | 367k | 2.92 | |
| Monte Rosa Therapeutics (GLUE) | 0.0 | $597k | 86k | 6.94 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $358k | 37k | 9.82 | |
| Kronos Bio | 0.0 | $118k | 124k | 0.95 |
